Dimed S.A. Distribuidora de Medicamentos (PNVL3) — Working Capital to Net Assets Ratio
Dimed S.A. Distribuidora de Medicamentos (PNVL3) has a Working Capital to Net Assets ratio of 73.9% as of March 2026. Working capital of R$961.14 Million (current assets of R$2.15 Billion minus current liabilities of R$1.18 Billion) is measured against net assets of R$1.30 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See financial flexibility index of Dimed S.A. Distribuidora de Medicamentos to measure the company's free cash flow as a share of total liabilities.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Dimed S.A. Distribuidora de Medicamentos Working Capital to Net Assets (2004–2025)
This chart shows how Dimed S.A. Distribuidora de Medicamentos's Working Capital to Net Assets ratio has evolved across 22 annual periods from 2004 to 2025. As of March 2026, the ratio stands at 73.9%, reflecting working capital of R$961.14 Million against net assets of R$1.30 Billion BRL. See PNVL3 days of operational coverage to measure how many days the company can operate on defensive assets alone.
Annual Working Capital to Net Assets for Dimed S.A. Distribuidora de Medicamentos (2004–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Dimed S.A. Distribuidora de Medicamentos from 2004 to 2025, covering 22 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see PNVL3 company net worth.
| Year | WC/NA Ratio | Working Capital (BRL) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 76.2% | R$976.92 Million | R$1.28 Billion | R$2.30 Billion | R$1.32 Billion | ▲ +9.2 pp |
| 2024 | 67.1% | R$827.92 Million | R$1.23 Billion | R$2.01 Billion | R$1.18 Billion | ▲ +6.9 pp |
| 2023 | 60.1% | R$705.65 Million | R$1.17 Billion | R$1.84 Billion | R$1.13 Billion | ▲ +10.5 pp |
| 2022 | 49.7% | R$550.31 Million | R$1.11 Billion | R$1.56 Billion | R$1.01 Billion | ▼ -5.8 pp |
| 2021 | 55.4% | R$580.11 Million | R$1.05 Billion | R$1.40 Billion | R$814.97 Million | ▼ -13.7 pp |
| 2020 | 69.1% | R$698.78 Million | R$1.01 Billion | R$1.38 Billion | R$677.72 Million | ▲ +2.4 pp |
| 2019 | 66.8% | R$349.89 Million | R$524.18 Million | R$851.14 Million | R$501.24 Million | ▲ +11.4 pp |
| 2018 | 55.4% | R$256.90 Million | R$463.91 Million | R$727.13 Million | R$470.23 Million | ▼ -15.2 pp |
| 2017 | 70.6% | R$301.26 Million | R$426.75 Million | R$705.02 Million | R$403.77 Million | ▲ +13.0 pp |
| 2016 | 57.6% | R$219.96 Million | R$381.65 Million | R$590.44 Million | R$370.48 Million | ▼ -7.5 pp |
| 2015 | 65.2% | R$224.28 Million | R$344.14 Million | R$539.88 Million | R$315.61 Million | ▼ -5.4 pp |
| 2014 | 70.6% | R$219.78 Million | R$311.30 Million | R$508.35 Million | R$288.56 Million | ▲ +9.1 pp |
| 2013 | 61.5% | R$170.22 Million | R$276.90 Million | R$421.17 Million | R$250.95 Million | ▼ -12.4 pp |
| 2012 | 73.8% | R$172.49 Million | R$233.64 Million | R$401.20 Million | R$228.72 Million | ▼ -0.1 pp |
| 2011 | 73.9% | R$147.30 Million | R$199.24 Million | R$361.47 Million | R$214.17 Million | ▼ -4.4 pp |
| 2010 | 78.3% | R$135.46 Million | R$173.03 Million | R$314.47 Million | R$179.01 Million | ▼ -3.8 pp |
| 2009 | 82.1% | R$124.69 Million | R$151.86 Million | R$282.22 Million | R$157.54 Million | ▲ +0.2 pp |
| 2008 | 81.9% | R$107.09 Million | R$130.81 Million | R$232.79 Million | R$125.70 Million | ▼ -0.9 pp |
| 2007 | 82.8% | R$103.79 Million | R$125.39 Million | R$221.79 Million | R$118.00 Million | ▼ -3.0 pp |
| 2006 | 85.8% | R$101.00 Million | R$117.74 Million | R$206.65 Million | R$105.66 Million | ▲ +1.3 pp |
| 2005 | 84.4% | R$91.35 Million | R$108.19 Million | R$190.24 Million | R$98.89 Million | ▲ +5.5 pp |
| 2004 | 78.9% | R$79.05 Million | R$100.20 Million | R$157.18 Million | R$78.13 Million | — |